These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16392385)

  • 1. [Potatoes against hepatitis].
    Bürger J
    Versicherungsmedizin; 2005 Dec; 57(4):197. PubMed ID: 16392385
    [No Abstract]   [Full Text] [Related]  

  • 2. Genes, greens, and vaccines.
    Ma JK
    Nat Biotechnol; 2000 Nov; 18(11):1141-2. PubMed ID: 11062427
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of the immunogenicity of hepatitis B surface antigen synthesized in transgenic potato plants with increased biosafety.
    Rukavtsova EB; Rudenko NV; Puchko EN; Zakharchenko NS; Buryanov YI
    J Biotechnol; 2015 Jun; 203():84-8. PubMed ID: 25840367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of hepatitis B surface antigen in transgenic plants for oral immunization.
    Richter LJ; Thanavala Y; Arntzen CJ; Mason HS
    Nat Biotechnol; 2000 Nov; 18(11):1167-71. PubMed ID: 11062435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral vaccines--a future prospect! Hepatitis vaccination in the vegetable market?].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Nov; 145(47):10. PubMed ID: 14725025
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody responses in mice stimulated by various doses of the potato-derived major surface antigen of hepatitis B virus.
    Youm JW; Won YS; Jeon JH; Moon KB; Kim HC; Shin KS; Joung H; Kim HS
    Clin Vaccine Immunol; 2010 Dec; 17(12):2029-32. PubMed ID: 20943879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity in humans of an edible vaccine for hepatitis B.
    Thanavala Y; Mahoney M; Pal S; Scott A; Richter L; Natarajan N; Goodwin P; Arntzen CJ; Mason HS
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3378-82. PubMed ID: 15728371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against hepatitis B in patients on chronic haemodialysis.
    Kovacic V
    Int J Clin Pract; 2003 Apr; 57(3):161-2. PubMed ID: 12723714
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral immunization of human with transgenic lettuce expressing hepatitis B surface antigen.
    Kapusta J; Modelska A; Pniewski T; Figlerowicz M; Jankowski K; Lisowa O; Plucienniczak A; Koprowski H; Legocki AB
    Adv Exp Med Biol; 2001; 495():299-303. PubMed ID: 11774582
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression and characterization of hepatitis B surface antigen in transgenic potato plants.
    Shulga NY; Rukavtsova EB; Krymsky MA; Borisova VN; Melnikov VA; Bykov VA; Buryanov YI
    Biochemistry (Mosc); 2004 Oct; 69(10):1158-64. PubMed ID: 15527417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate mucosal vaccine against hepatitis B based on tomatoes transgenic for the preS2-S gene.
    Salyaev RK; Rekoslavskaya NI; Stolbikov AS; Tret'yakova AV
    Dokl Biochem Biophys; 2012; 446():257-9. PubMed ID: 23132723
    [No Abstract]   [Full Text] [Related]  

  • 12. Potato vaccine for hepatitis.
    AIDS Patient Care STDS; 1999 Nov; 13(11):682. PubMed ID: 10743515
    [No Abstract]   [Full Text] [Related]  

  • 13. Production of hepatitis B surface antigen in recombinant plant systems: an update.
    Kumar GB; Ganapathi TR; Bapat VA
    Biotechnol Prog; 2007; 23(3):532-9. PubMed ID: 17348684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.
    Shouval D; Roggendorf H; Roggendorf M
    Med Microbiol Immunol; 2015 Feb; 204(1):57-68. PubMed ID: 25557605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The obtaining of transgenic tomato plant producing chimerical proteins TBI-HBsAg.
    Shchelkunov SN; Salyaev RK; Rekoslavskaya NI; Ryzhova TS; Pozdnyakov SG; Sumtsova VM; Pakova NV; Mishutina UO; Kopytina TV; Hammond R
    Dokl Biochem Biophys; 2004; 396():139-42. PubMed ID: 15378910
    [No Abstract]   [Full Text] [Related]  

  • 16. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis B vaccination.
    Romanò L; Paladini S; Galli C; Raimondo G; Pollicino T; Zanetti AR
    Hum Vaccin Immunother; 2015; 11(1):53-7. PubMed ID: 25483515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
    Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
    Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral vaccination of mice with Tremella fuciformis yeast-like conidium cells expressing HBsAg.
    Shin DI; Song KS; Park HS
    Biotechnol Lett; 2015 Mar; 37(3):539-44. PubMed ID: 25374008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.